TB vaccines have relied on a CD4 + Th1 TL response for immunogenicity stage determination of candidate vaccines; however, the full protection mechanism is not yet well-understood and it has been suggested that IFN-γ production by this cellular subset alone is neither sufficient nor fully predictive of clinical vaccine efficacy (Lu et al. 2019). Here, IFNG is linked to tuberculosis.